medigraphic.com
ISSN 1729-519X (Print)

2019, Number 3

<< Back Next >>

Revista Habanera de Ciencias Médicas 2019; 18 (3)

Prevalence of diabetes mellitus in patients with treatment for tuberculosis in a public hospital in Colombia

Yaneth-Giovanetti MC, Morales PGI, Herrera N, Prasca AJ

Language: Spanish
References: 26
Page: 477-486
PDF size: 589.26 Kb.


ABSTRACT

Introduction: Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. Diabetes Mellitus is among the risk factors for the development of Tuberculosis. People with active Tuberculosis and diabetes can be negatively complicated by the results of Tuberculosis treatment, delaying the time of microbiological response which increases the probability of an unfavorable result and the risk of relapse, drug resistance, and death in some cases.
Objective: To establish the prevalence of Diabetes mellitus and its correlation with risk factors in patients with Tuberculosis who underwent treatment in a public Hospital in Valledupar, Colombia.
Material and Methods: A cross-sectional descriptive study was carried out in all cases diagnosed with Tuberculosis that underwent treatment in a public Hospital in Valledupar, Colombia. The diagnosis of diabetes was made with the use of a test to measure basal glycemia, the clinical histories of the patients, and surveys. All participants were surveyed for the evaluation of risk factors:
Results: Of the 70 patients with Tuberculosis, 8 (11.4%) were diagnosed with DM. It was observed that the age> 40 years (p = 0.030) constitutes a risk factor for the TB-DM binomial; but there was no statistically significant difference with regard to sex, alcohol consumption, tobacco consumption, HIV, and body mass index (p> 0.05).
Conclusions: The prevalence of Diabetes mellitus-Tuberculosis binomial in the Hospital studied corresponds to the figures established by the World Health Organization (WHO).


REFERENCES

  1. Paneque Ramos E, Rojas Rodríguez LY, Pérez Loyola M. La Tuberculosis a través de la Historia: un enemigo de la humanidad. Rev haban cienc méd [Internet]. 2018, [consultado: 26/11/2018], 17(3): 353-363. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext &pid=S1729-519X2018000300353&lng=es.

  2. Organización Mundial de la Salud. [Internet]. Ginebra. Suiza: OMS; 2017. Informe Mundial sobre la Tuberculosis 2017. Sinopsis. [consultado 07/03/2019], Disponible en: http://www.who.int/campaigns/tbday/ 2018/exe_summary_es.pdf

  3. Rodriguez S, Vazquez R, Ruy-Díaz-Reynoso, S.J.A. Tuberculosis concomitant with diabetes. Revista médica del Hospital General. [Internet]. 2015. [consultado 07/03/2019], 4:183-187. Disponible en: http://www.elsevier.es/en-revista-revista-medica-delhospital- general-325-pdf-S0185106315000530

  4. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. [Internet]. 2009; [consultado 07/03/2019], 9(12):737-46. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC29458 09/

  5. Li Xueqing, Kou Shunchao, Blanco Aspiazu Miguel Ángel. Abordaje de los mecanismos de comorbilidad en Diabetes Mellitus Tipo 2. Rev haban cienc méd. [Internet]. 2017, [consultado 26/11/2018], 16(6): 891-901. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext &pid=S1729-519X2017000600006&lng=es

  6. Ibrahim E, Ibrahim Baess A, Al Messery MA. Pattern of prevalence, risk factors and treatment outcomes among Egyptian patients with multidrug resistant tuberculosis. Egyptian Journal of Chest Diseases and Tuberculosis. [Internet]. 2017, [consultado 26/11/2018] 66(3):405–411. Disponible en: https://ac.els-cdn.com/S0422763816302370/1-s2.0- S0422763816302370-main.pdf?_tid=9369a4e5-cc98- 49e7-90b0- aa0e89df1d98&acdnat=1543310518_bf1dade7765bc3c e2f0bb810c3ff0032

  7. Mendenhall E, Kohrt BA, Norris S, Ndetei D, Prabhakaran D. Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations Lancet. [Internet]. 2017. [consultado 07/03/2019], 389(10072):951–963. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC54913 33/

  8. WHO. World Health Organization & International Union Against Tuberculosis and Lung Disease. [Internet]. Ginebra. Suiza: WHO; 2011. Collaborative framework for care and control of tuberculosis and diabetes. [consultado 07/03/2019], 53p Disponible en: https://apps.who.int/iris/bitstream/handle/10665/446 98/9789241502252_eng.pdf?sequence=1

  9. American Diabetes Association. US National Library of Medicine. National Institutes of Health. Standards of Medical Care in Diabetes—2015 Abridged for Primary Care Providers. Clinical Diabetes. [Internet]. 2015, [consultado 07/03/2019], 33(2): 97-111. Disponible en: http://clinical.diabetesjournals.org/content/33/2/97.ful l-text.pdf

  10. Ministerio de Salud y Protección Social Departamento Administrativo de Ciencia, Tecnología e Innovación – Colciencias- [Internet]. Colombia: Colciencias; 2016. Guía de práctica clínica para el diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años. [consultado 07/03/2019].1-606p. Disponible en: http://gpc.minsalud.gov.co/gpc_sites/Repositorio/Conv _637/GPC_diabetes/DIABETES_TIPO_2_COMPLETA.pdf

  11. Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis - a systematic review. BMC Public Health [Internet]. 2008 [consultado 10/03/2019]; 8:289,1-12. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC25333 27/

  12. Zahr R, Peterson R, Polgreen L, Cavanaugh J, Hornick D, Winthrop K, et al. Diabetes as an increasingly common comorbidity among patient hospitalizations for tuberculosis in the USA. BMJ Open Diabetes Res Care. 2016;4:e000268.

  13. Perez-Navarro M, Restrepo BI, Fuentes DF, Duggirala R, Morales-Romero J, López-Alvarenga JC, Comas I, Zenteno-Cuevas R. The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes. Tuberculosis. 2017. 103:83-91.

  14. Pinto CMA, Carvalho ARM. Diabetes mellitus and TB co-existence: Clinical implications from a fractional order modelling. 2019. Applied Mathematical Modelling. 68:219-243.

  15. Herrera T, Leiva E, Martín F, Miranda M, Morales C. (2013). Asociación entre tuberculosis y diabetes mellitus en la Región Metropolitana. Rev Chil Enf Respir. [Internet]. 2013, [consultado: 26/11/2018], 29:171-175. Disponible en: https://scielo.conicyt.cl/pdf/rcher/v29n3/art08.pdf

  16. Ogbera AO, Kapur A, Abdur-Razzaq H, Harries AD, Yamiya K, Adeleye O et al Cliical Profile of diabetes mellitus in tuberculosis. BMJ Open Diabetes Research and Care. 2015; 3:e000112.

  17. Raghuraman S, Vasudevan KP, Govindarajan S, Chinnakali P, Panigrahi KC. Prevalence of Diabetes Mellitus among Tuberculosis Patients in Urban Puducherry. N Am J Med Sci. [Internet]. 2014, [consultado 07/03/2019], 6(1):30-34. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC39388 70/

  18. Organización Panamericana de la Salud (OPS) y Organización Mundial de la Salud (OMS). [Internet]. Ginebra. Suiza: OPS/OMS; 2018. Tuberculosis en las Américas 2018. [consultado 07/03/2019]. 24p. Disponible en: http://iris.paho.org/xmlui/bitstream/handle/12345678 9/49510/OPSCDE18036_spa?sequence=2&isAllowed=y

  19. Tankeu AT, Bigna JJ, Nansseu JR, Endomba FTA, Wafeu GS, Kaze AD et al. Global prevalence of diabetes mellitus in patients with tuberculosis: a systematic review and meta-analysis protocol. BMJ Open. [Internet]. 2017, [consultado 07/03/2019], 7(6):1-4. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC57342 53/pdf/bmjopen-2016-015170.pdf

  20. Pal R, Ansari M, Hameed S, Fatima Z. Diabetes mellitus as hub for tuberculosis infection: A snapshot. International Journal Chronic Diseases. 2016. Article ID 5981574, 7:1-7.

  21. Achanta S, Tekumalla R, Jaju J, Purad, C, Chepuri R, Samyukta R, Malhotra S, Harries AD. Screning tuberculosis patients for diabetes in a tribal area in South India. Public Health Action. [Internet]. 2013, [consultado 07/03/2019], 3(Suppl 1):S43-S47. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC44631 45/pdf/S43.pdf

  22. Instituto Nacional de Salud. (INS). [Internet]. Colombia: INS; 2017. Informe del Evento Tuberculosis, Colombia, 2017. [consultado 07/03/2019]. 1-21p. Disponible en: https://www.ins.gov.co/buscadoreventos/ Informesdeevento/Tuberculosis%202017.pdf

  23. Mukhtar F, Butt ZA. Risk of adverse treatment outcomes among new pulmonary TB patients coinfected with diabetes in Pakistan: A prospective cohort study. Journal of Epidemiology and Global Health. [Internet]. 2018. [consultado 08/03/2019] 13:249-254 Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/30408109

  24. Pérez A, Brown HS, Restrepo BI. Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas. The American Journal of Tropical Medicine and Hygiene. [Internet]. 2006. [consultado 07/03/2019], 74(4):604–611. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC14641 39/pdf/nihms9814.pdf

  25. Pérez Navarro LM. Caracterización y estimación de factores asociados a tuberculosis pulmonar en pacientes con y sin diabetes mellitus del Estado de Veracruz. [tesis de maestría]. México: Universidad Veracruzana; 2009. 95p [consultado 07/03/2019]. Disponible en: https://cdigital.uv.mx/handle/123456789/29985

  26. Echazarreta A, Zerbini E, De Sandro J, Sáenz C, Yessi L, Saad R, Manonelles G, Cuello M. Tuberculosis y comorbilidades en áreas urbanas de Argentina. Una perspectiva de edad y sexo. Biomédica [Internet]. 2018 [consultado 10/03/2019];38(2):180-8. Disponible en: https://www.revistabiomedica.org/index.php/biomedic a/article/view/3904




2020     |     www.medigraphic.com